Literature DB >> 9685273

Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia.

N Tarrier1, L Yusupoff, C Kinney, E McCarthy, A Gledhill, G Haddock, J Morris.   

Abstract

OBJECTIVES: To investigate whether intensive cognitive behaviour therapy results in significant improvement in positive psychotic symptoms in patients with chronic schizophrenia.
DESIGN: Patients with chronic schizophrenia were randomly allocated, stratified according to severity of symptoms and sex, to intensive cognitive behaviour therapy and routine care, supportive counselling and routine care, and routine care alone.
SETTING: Adjunct treatments were carried out in outpatient clinics or in the patient's home.
SUBJECTS: 87 patients with persistent positive symptoms who complied with medication; 72 completed treatment. OUTCOME MEASURES: Assessments of positive psychotic symptoms before treatment and 3 months after treatment. Number of patients who showed a 50% or more improvement in symptoms. Exacerbation of symptoms and rates of readmission to hospital.
RESULTS: Significant improvements were found in the severity (F=5.42, df =2,86; P=0.006) and number (F=4.99, df=2,86; P=0.009) of positive symptoms in those treated with cognitive behaviour therapy. The supportive counselling group showed a non-significant improvement. Significantly more patients treated with cognitive behaviour therapy showed an improvement of 50% or more in their symptoms (chi2=5.18, df=1; P=0.02). Logistic regression indicated that receipt of cognitive behaviour therapy results in almost eight times greater odds (odds ratio 7.88) of showing this improvement. The group receiving routine care alone also experienced more exacerbations and days spent in hospital.
CONCLUSIONS: Cognitive behaviour therapy is a potentially useful adjunct treatment in the management of patients with chronic schizophrenia.

Entities:  

Mesh:

Year:  1998        PMID: 9685273      PMCID: PMC28621          DOI: 10.1136/bmj.317.7154.303

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  8 in total

1.  Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms.

Authors:  V Drury; M Birchwood; R Cochrane; F Macmillan
Journal:  Br J Psychiatry       Date:  1996-11       Impact factor: 9.319

Review 2.  Individual cognitive-behavior therapy in the treatment of hallucinations and delusions: a review.

Authors:  G Haddock; N Tarrier; W Spaulding; L Yusupoff; C Kinney; E McCarthy
Journal:  Clin Psychol Rev       Date:  1998-11

3.  Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council fluphenazine/placebo trial I. Course of illness, stability of diagnosis, and the role of a special maintenance clinic.

Authors:  D A Curson; T R Barnes; R W Bamber; S D Platt; S R Hirsch; J C Duffy
Journal:  Br J Psychiatry       Date:  1985-05       Impact factor: 9.319

4.  London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: effects of the treatment phase.

Authors:  E Kuipers; P Garety; D Fowler; G Dunn; P Bebbington; D Freeman; C Hadley
Journal:  Br J Psychiatry       Date:  1997-10       Impact factor: 9.319

5.  A standardized psychiatric assessment scale for rating chronic psychotic patients.

Authors:  M Krawiecka; D Goldberg; M Vaughan
Journal:  Acta Psychiatr Scand       Date:  1977-04       Impact factor: 6.392

6.  Cognitive behavioural therapy for drug-resistant psychosis.

Authors:  P A Garety; L Kuipers; D Fowler; F Chamberlain; G Dunn
Journal:  Br J Med Psychol       Date:  1994-09

7.  A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome.

Authors:  N Tarrier; R Beckett; S Harwood; A Baker; L Yusupoff; I Ugarteburu
Journal:  Br J Psychiatry       Date:  1993-04       Impact factor: 9.319

8.  Symptom monitoring in the rehabilitation of schizophrenic patients.

Authors:  D Lukoff; R P Liberman; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1986       Impact factor: 9.306

  8 in total
  39 in total

Review 1.  Who is suitable for cognitive behavioural therapy?

Authors:  P Blenkiron
Journal:  J R Soc Med       Date:  1999-05       Impact factor: 5.344

2.  Cognitive therapy is no better than supportive counselling in schizophrenia.

Authors:  D Curtis
Journal:  BMJ       Date:  1999-09-04

3.  Psychotherapy of Schizophrenia.

Authors: 
Journal:  J Psychother Pract Res       Date:  2000-10

4.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

Review 5.  A clinical review of cognitive therapy for schizophrenia.

Authors:  Neil A Rector; Aaron T Beck
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

Review 6.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

7.  Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses.

Authors:  Mario Pfammatter; Ulrich Martin Junghan; Hans Dieter Brenner
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

8.  Cognitive behavior therapy for people with schizophrenia.

Authors:  Ann K Morrison
Journal:  Psychiatry (Edgmont)       Date:  2009-12

Review 9.  The evolution of cognitive behavior therapy for schizophrenia: current practice and recent developments.

Authors:  Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-08-06       Impact factor: 9.306

Review 10.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.